Cargando…

Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes

We determined whether plasma concentrations of the receptor for advanced glycation end products (RAGE) and the soluble (s) form of RAGE (sRAGE) in healthy individuals and patients with type 2 diabetes (T2D) modulate vascular remodeling. Healthy individuals and patients with T2D were divided into two...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsoporis, James N., Hatziagelaki, Erifili, Gupta, Sahil, Izhar, Shehla, Salpeas, Vasileos, Tsiavou, Anastasia, Rigopoulos, Angelos G., Triantafyllis, Andreas S., Marshall, John C., Parker, Thomas G., Rizos, Ioannis K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696395/ https://www.ncbi.nlm.nih.gov/pubmed/33182705 http://dx.doi.org/10.3390/molecules25225235

Ejemplares similares

Differential Regulation of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGEs) and Its Ligands S100A8/A9 Four Weeks Post an Exercise Intervention in a Cohort of Young Army Recruits
por: Drosatos, Ioannis-Alexandros, et al.
Publicado: (2021)

Cytoprotective Mechanisms of DJ-1: Implications in Cardiac Pathophysiology
por: Tsoporis, James N., et al.
Publicado: (2021)

Predictors of Impaired Glucose Regulation in Patients with Non-Alcoholic Fatty Liver Disease
por: Hatziagelaki, Erifili, et al.
Publicado: (2012)

Emergent Inflammatory Markers and Echocardiographic Indices in Patients with Bronchial Asthma
por: Gkavogiannakis, Nikolaos A., et al.
Publicado: (2023)

Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Hatziagelaki, Erifili, et al.
Publicado: (2015)

DJ-1 Deficiency Protects against Sepsis-Induced Myocardial Depression
por: Tsoporis, James N., et al.
Publicado: (2023)

Correction: Let-7, Mir-98 and Mir-181 as Biomarkers for Cancer and Schizophrenia
por: Rizos, Emmanouil, et al.
Publicado: (2015)

Let-7, Mir-98 and Mir-181 as Biomarkers for Cancer and Schizophrenia
por: Rizos, Emmanouil, et al.
Publicado: (2015)

Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillation
por: Kalogeropoulos, Andreas S, et al.
Publicado: (2011)

Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus
por: Guthoff, Martina, et al.
Publicado: (2017)

Effects of olanzapine on cytokine profile and brain-derived neurotrophic factor in drug-naive subjects with first-episode psychosis
por: Hatziagelaki, Erifili, et al.
Publicado: (2019)

Evaluation of Quality of Life and Emotional Disturbances in Patients with Diabetic Retinopathy
por: Saitakis, George, et al.
Publicado: (2023)

Soluble Forms of the Receptor for Advanced Glycation Endproducts (RAGE) in Periodontitis
por: Detzen, Laurent, et al.
Publicado: (2019)

Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging
por: Scavello, Francesco, et al.
Publicado: (2019)

Peroxisome proliferator-activated receptor gamma (PPARG) modulates free fatty acid receptor 1 (FFAR1) dependent insulin secretion in humans
por: Wagner, Robert, et al.
Publicado: (2014)

Diet, life-style and cardiovascular morbidity in the rural, free living population of Elafonisos island
por: Kapelios, Chris J., et al.
Publicado: (2017)

Soluble receptor for advanced glycation end-products and progression of airway disease
por: Iwamoto, Hiroshi, et al.
Publicado: (2014)

Soluble receptors for advanced glycation end products and receptor activator of NF-κB ligand serum levels as markers of premature labor
por: Rzepka, Rafał, et al.
Publicado: (2015)

The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases
por: Steenbeke, Mieke, et al.
Publicado: (2022)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
por: Pratte, Katherine A., et al.
Publicado: (2021)

Skin Autofluorescence Relates to Soluble Receptor for Advanced Glycation End-Products and Albuminuria in Diabetes Mellitus
por: Škrha, J., et al.
Publicado: (2013)

Brain “fog,” inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin
por: Theoharides, Theoharis C., et al.
Publicado: (2015)

Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary Syndrome
por: Jensen, Louise J. N., et al.
Publicado: (2015)

Decreased Soluble Receptor of Advanced Glycation End Product Levels Correlated with Inflammation in Silicosis
por: Liu, Heliang, et al.
Publicado: (2020)

Soluble Receptor for Advanced Glycation End-products regulates age-associated Cardiac Fibrosis
por: Scavello, Francesco, et al.
Publicado: (2021)

Cytokine soluble receptors in perinatal and early neonatal life.
por: Protonotariou, Efthimia, et al.
Publicado: (2003)

A Combination of Mediterranean and Low-FODMAP Diets for Managing IBS Symptoms? Ask Your Gut!
por: Kasti, Arezina, et al.
Publicado: (2022)

Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study
por: Jabaudon, Matthieu, et al.
Publicado: (2015)

Serum Adiponectin, Resistin, and Circulating Soluble Receptor for Advanced Glycation End Products in Colectomy Patients
por: Asgeirsson, Theodor, et al.
Publicado: (2011)

Soluble Form of Receptor for Advanced Glycation End Products Is Associated with Obesity and Metabolic Syndrome in Adolescents
por: He, Chih-Tsueng, et al.
Publicado: (2014)

The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype
por: Miłkowska-Dymanowska, Joanna, et al.
Publicado: (2018)

The Relationship between Plasma Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease
por: Wang, Xiangming, et al.
Publicado: (2019)

Soluble Receptor for Glycation End-products Concentration Increases Following the Treatment of Severe Diabetic Ketoacidosis
por: Hoffman, William H., et al.
Publicado: (2020)

Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study
por: Wu, Shou-En, et al.
Publicado: (2021)

Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques
por: Pinto, Raphael S, et al.
Publicado: (2022)

Receptor for Advanced Glycation Endproducts (RAGE), Its Ligands, and Soluble RAGE: Potential Biomarkers for Diagnosis and Therapeutic Targets for Human Renal Diseases
por: Lee, Eun Ji, et al.
Publicado: (2013)

Influence of Physical Activity Intervention on Circulating Soluble Receptor for Advanced Glycation end Products in Elderly Subjects
por: Kotani, Kazuhiko, et al.
Publicado: (2011)

Soluble receptor for advanced glycation end products as an indicator of pulmonary vascular injury after cardiac surgery
por: Tuinman, Pieter R, et al.
Publicado: (2013)

Serum soluble receptor of advanced glycation end products and risk of metabolic syndrome in Egyptian obese women
por: Zaki, Moushira, et al.
Publicado: (2017)

Differential Expression of Soluble Receptor for Advanced Glycation End-products in Mice Susceptible or Resistant to Chronic Colitis
por: Bramhall, Michael, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ccuh21s7n9s6leeqfq8jm7d9c5